Company Page Hero
Changing the Story of Lung Cancer

Ethicon is partnering with healthcare leaders worldwide, 
developing innovative solutions aimed at boosting 
long-term survival rates for lung cancer patients.

Shaping the Future of Surgery

Transforming Lives Together

Ethicon is committed to the fight against obesity and metabolic diseases, helping to elevate the standard of care and expanding patient access to care. 

Over a Century of Meaningful Innovation

At Ethicon, weʼre focused on improving health outcomes for patients and helping solve the greatest health challenges… with only meaningful innovation. The kind that led to the creation of the first sutures, that helped revolutionize surgery with minimally invasive procedures, and that elevates standards of care around the world.

Partnering with IHPBA and AHPBA

Partnering with IHPBA and AHPBA

Ethicon partners with IHPBA and AHPBA to develop Pre-Op Planning Modules

These modules are an exciting new resource now available on the myHPB platform. They emphasize recognizing procedure and patient-specific key decision-making points during preoperative planning. They also feature expert surgeons describing their “slowing down” moments during standard procedures. 

News & Events
Teaser Image
Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.
Auris Health’s Robotic Platform Expands Johnson & Johnson’s Digital Surgery Portfolio
Teaser Image
New Study Suggests Surgical Stapler May Play Important Role in Reducing Common Complication Associated With Lung Surgery
Greater than Two-to-One Difference in Thoracic Surgery Air Leak Incidence
Teaser Image
New Study Highlights Impact of Surgical Staplers on Tissue and Staple-Line Healing
Ethicon ECHELON FLEX™ GST System is associated with a stronger staple line and higher leak pressures when compared to Endo GIA™ Reload with Tri-Staple™ Technology
Teaser Image
New Survey Finds One-Third of Americans Say They or Someone They Know Have Been “Fat Shamed” in the Past Year
References

* Benchtop testing in porcine tissue ≤30mmHg (26mmHg average pressure experienced during intra-operative leak test), comparing Ethicon ECHELON CIRCULAR™ Powered Stapler CDH25P to Medtronic DST Series™ EEA™ Stapler EEA2535 (p<0.001) and preclinical perfusion model, in which perfusion was not significantly different between devices.

† System components include ECHELON FLEX™ Powered Plus Stapler and ECHELON ENDOPATH™ Reloads with Gripping Surface Technology.

  1. Ethicon retrospective analysis of economic and clinical outcomes comparing the use of Echelon Powered vs. Medtronic non-powered endoscopic surgical staplers to treat patients undergoing video-assisted thoracoscopic surgery lobectomy.Review of 3,006 cases between 2012 and 2015 from the Premier Perspective® Hospital Database. Data assessed included length of stay, total hospital cost, supply cost, room & board cost, incidence of transfusion, and incidence of hemostasis-related complications; all p ≤ 0.05.
  2. Ethicon retrospective analysis of clinical outcomes between Echelon Powered vs. Medtronic non-powered endoscopic surgical staplers among patients undergoing video-assisted thoracoscopic surgery lobectomy. Review of 1,501 cases between 2012 and 2015 from the Premier Perspective® Hospital Database (4.8% vs. 14.2%;p=0.0098).
  3. Ethicon retrospective analysis of economic and clinical outcomes between Echelon Powered vs. Medtronic non-powered endoscopic surgical staplers among patients undergoing video-assisted thoracoscopic surgery lobectomy. Review of 3,006 cases between 2012 and 2015 from the Premier Perspective® Hospital Database. Length of stay:4.9 vs 5.7 days; p=0.0374, Total hospital cost: $23,785 vs. $26,180; p=0.0078, Supply cost: $5,021 vs. $5,989; p=0.0161, Room & board cost: $6,792 vs. $7,984; p=0.0385, Transfusion: 4.7% vs. 9.3%; p=0.018, Hemostasis-related complications: 8.2% vs. 13.9%; p=0.0218.
  4. Ethicon retrospective analysis of outcomes between Echelon Powered vs. Medtronic non-powered endoscopic surgical staplers among patients undergoing video-assisted thoracoscopic surgery lobectomy. Review of 1,051 cases between 2012 and 2015 from the Premier Perspective® Hospital Database. Hemostasis-related complications: 4.8% vs. 14.2%; p=0.010. Transfusion: 3.0% vs. 9.4%; p=0.023. Total hospital costs: $23,219 vs. $25,207; p=0.242.
  5. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. doi:10.1001/jamasurg.2017.0904.
  6. WHO Global Guidelines for the Prevention of Surgical Site Infection, 2016.
  7. Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2016;224:59-74.
  8. ENSEAL® X1 Curved Jaw Tissue Sealer can capture, seal and transect a longer length of tissue per single activation due to a 16% (or 3.4mm) longer jaw (p < 0.001), a 40% (or 5.0mm) wider unbiased jaw aperture (p < 0.001) and a 19% (or 3.6mm) longer cut length (p < 0.001) compared to LigaSure™ Maryland (LF1937) (C2841).
  9. 100326296: Time Zero Tissue Holding - Competitive Claims Comparisons for STRATAFIX Knotless Tissue Control Devices vs Various Products. 2015.

  10. Performance Testing of STRATAFIX SYMMETRIC PDS PLUS Size 0 & 1 Devices – Initiation Strength in Porcine Tissue. AST-2013-0603. 
  11. AST-2013-0056 Performance Testing of STRATAFIX Symmetric PDSSize2-0 suture device for Tissue Holding Strength with Multiple Incision Defects to Measure Gapping.
  12. 
Ethicon study PSE 09-0204, project number 11822. Exploratory histological and biomechanical evaluation of DOLFIN following closure of the ventral abdominal wall in a porcine model at 7±1 days. Approved on July 7, 2010. 
  13. 
Ethicon Performance Evaluation Memo AST-2012-0510. Performance Testing of STRATAFIX Symmetric Size 2-0 suture device for Tissue Holding Strength with an Incision Defect to Measure Gapping. Dated December 3, 2012. 
  14. STRATAFIX Symmetric PDS Plus Knotless Tissue Control Device. Instructions for Use. Ethicon, Inc. 

  15. Data on file, Ethicon. Powder TTH vs Original Final Report. 2015.

  16. Data on file, Ethicon. Final Report, PSE Accession No. 16-0006. Project No. 16438.

  17. Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobial evaluation of coated Vicryl Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect. 2002;3(suppl):S79-S87

  18. P960052B.

  19. Data on File. Keplinger 07PD0748. Protocol investigation of the comparison of PRINEO with conventional wound closure techniques.  

  20. Chalmers RT, Darling RC III, Wingard JT, et al. Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures. Br J Surg. 2010;97(12):1784–1789. 

  21. STAR ASA coverage area test using corium tissue on a 45 degree tilted plane. September 2014. Ethicon, Inc. 

  22. Ex-vivo data available in probe Instructions For Use. See PL-000006, PL-000009, PL-000026, PL-000050, PL-000239, PL-000240 and PL-000243.

  23. Laeseke et al. Multiple-Antenna Microwave Ablation: Spatially Distributing Power Improves Thermal Profiles and Reduces Invasiveness. Journal of Interventional Oncology. 2009; 2(2):105-112. Brace et al. Simultaneous Activation of Multiple Microwave Antennas Improves Circularity and Ablation Zone Volume Compared to Sequentially Overlapping Ablations. Presented at conference with accompanying poster, WCIO 2014.

For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.